19 related articles for article (PubMed ID: 38546343)
1. Silencing METTL14 alleviates liver injury in non-alcoholic fatty liver disease by regulating mitochondrial homeostasis.
Wang W; Yan J; Han L; Zou ZL; Xu AL
Biomol Biomed; 2024 May; 24(3):505-519. PubMed ID: 37902450
[TBL] [Abstract][Full Text] [Related]
2. METTL14 affects UVB-induced human dermal fibroblasts photoaging via miR-100-3p biogenesis in an m
Chen L; Hu Y; Zhang M; Liu L; Ma J; Xu Z; Zhang J; Gu H; Chen K
Aging Cell; 2024 May; 23(5):e14123. PubMed ID: 38380598
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of METTL14-mediated m
Gong S; Wang S; Shao M
J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
[TBL] [Abstract][Full Text] [Related]
5. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
Tan X; Song X; Fan B; Li M; Zhang A; Pei L
Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
7. METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression.
Qian S; Liu J; Liao W; Wang F
Genes Genomics; 2024 Feb; 46(2):213-229. PubMed ID: 37594665
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation.
Wu C; Miao C; Zhou S; Chang PA; He B; Zhou X; Tang Q
Environ Toxicol; 2024 Jun; 39(6):3734-3745. PubMed ID: 38546343
[TBL] [Abstract][Full Text] [Related]
9. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer.
Chen L; Xu YX; Wang YS; Ren YY; Chen YM; Zheng C; Xie T; Jia YJ; Zhou JL
J Ethnopharmacol; 2024 Sep; 331():118265. PubMed ID: 38677579
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]